Institutional investors purchased a net $271.4 thousand shares of OXGN during the quarter ended September 2014, and now own 19.57% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 880.9 Thousand shares of OXiGENE Inc